Russell Investments Group Ltd. Has $1.70 Million Position in BioSpecifics Technologies Corp (BSTC)

Russell Investments Group Ltd. cut its position in BioSpecifics Technologies Corp (NASDAQ:BSTC) by 0.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 34,266 shares of the biopharmaceutical company’s stock after selling 185 shares during the period. Russell Investments Group Ltd. owned 0.48% of BioSpecifics Technologies Corp worth $1,697,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Bank of America Corp DE lifted its position in shares of BioSpecifics Technologies Corp by 122.6% during the 1st quarter. Bank of America Corp DE now owns 2,489 shares of the biopharmaceutical company’s stock worth $137,000 after buying an additional 1,371 shares in the last quarter. US Bancorp DE raised its holdings in shares of BioSpecifics Technologies Corp by 1.1% in the 2nd quarter. US Bancorp DE now owns 3,455 shares of the biopharmaceutical company’s stock worth $171,000 after purchasing an additional 36 shares during the period. American International Group Inc. raised its holdings in shares of BioSpecifics Technologies Corp by 7.1% in the 1st quarter. American International Group Inc. now owns 3,327 shares of the biopharmaceutical company’s stock worth $182,000 after purchasing an additional 222 shares during the period. Public Employees Retirement System of Ohio raised its holdings in shares of BioSpecifics Technologies Corp by 16.2% in the 1st quarter. Public Employees Retirement System of Ohio now owns 3,674 shares of the biopharmaceutical company’s stock worth $201,000 after purchasing an additional 513 shares during the period. Finally, Bank of Montreal Can raised its holdings in shares of BioSpecifics Technologies Corp by 10.6% in the 1st quarter. Bank of Montreal Can now owns 7,272 shares of the biopharmaceutical company’s stock worth $398,000 after purchasing an additional 699 shares during the period. 55.95% of the stock is currently owned by institutional investors and hedge funds.

BioSpecifics Technologies Corp (NASDAQ:BSTC) opened at 46.38 on Friday. BioSpecifics Technologies Corp has a 12 month low of $38.89 and a 12 month high of $58.79. The company has a 50-day moving average of $46.68 and a 200 day moving average of $50.85. The stock has a market capitalization of $332.27 million, a price-to-earnings ratio of 28.45 and a beta of 1.76.

TRADEMARK VIOLATION NOTICE: This article was first posted by BBNS and is the property of of BBNS. If you are accessing this article on another site, it was illegally copied and reposted in violation of United States and international copyright legislation. The legal version of this article can be read at https://baseballnewssource.com/markets/russell-investments-group-ltd-sells-185-shares-of-biospecifics-technologies-corp-bstc/1593606.html.

A number of research analysts recently weighed in on BSTC shares. Zacks Investment Research upgraded shares of BioSpecifics Technologies Corp from a “sell” rating to a “hold” rating in a research note on Tuesday, July 11th. BidaskClub lowered shares of BioSpecifics Technologies Corp from a “hold” rating to a “sell” rating in a research report on Wednesday, August 2nd. Finally, HC Wainwright set a $72.00 price target on shares of BioSpecifics Technologies Corp and gave the company a “buy” rating in a research report on Thursday, August 10th.

BioSpecifics Technologies Corp Profile

BioSpecifics Technologies Corp. is a biopharmaceutical company involved in the development of an injectable collagenase clostridium histolyticum for multiple indications. The Company has a development and license agreement with Endo Global Ventures, a Bermuda unlimited liability company (Endo Global Ventures), an affiliate of Endo International plc (Endo), for injectable collagenase for marketed indications and indications in development.

Institutional Ownership by Quarter for BioSpecifics Technologies Corp (NASDAQ:BSTC)

Receive News & Ratings for BioSpecifics Technologies Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSpecifics Technologies Corp and related companies with our FREE daily email newsletter.

 


Latest News

Young Girl Hit by Foul Ball Rushed to Hospital
Young Girl Hit by Foul Ball Rushed to Hospital
New Home Run Record Reached in Major League Baseball
New Home Run Record Reached in Major League Baseball
Will 2017 MLB Season End with No 20-Game Winner?
Will 2017 MLB Season End with No 20-Game Winner?
Cleveland Indians Winning Streak Snapped at 22
Cleveland Indians Winning Streak Snapped at 22
Tigers Player Might Play All Nine Positions During Same Game
Tigers Player Might Play All Nine Positions During Same Game
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster
Fans Kicked Out of Fenway Park After Racist Banner Hung on Green Monster


Leave a Reply

 
© 2006-2017 BBNS.